About this trial
The aim of this observational study is to identify biomarkers in extracellular vesicles associated with medullary adiposity occurring in patients with anorexia nervosa. The main question it aims to answer is:
Can this medullary adiposity be associated with the bone deterioration observed in this population?
Participants will be assessed for body composition and a blood sample will be taken by non-invasive techniques.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Diagnosis of active AN according to DSM-5 criteria
BMI of less than 17kg/m2
Present amenorrhoea in the 3 months prior to the start of the study.
Achieved weight gain of more than 85%.
Disqualifiers
Not receiving oestrogens, contraceptives or glucocorticoids in the 3 months prior to the start of the study.
Not to suffer from chronic diseases, such as diabetes, pathologies affecting the bone system or thyroid function.
Do not take calcium or vitamin supplements.
Trial population
The study population will consist of patients diagnosed with active anorexia nervosa according to DSM-V criteria (AN group), with a clinical history in the Clinical Management Unit of Endocrinology and Nutrition of the HURS, patients recovered from the disease (AN-R group) and healthy population of the same age and gender as the patients in the previous groups (CON group).
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Biomarkers related to medullary adiposity
Blood samples to isolate extracellular vesicles for omics studies
Secondary outcomes
Bone Mineral Density
Bone mineral density measured by densitometry
Body Composition
Fat and muscle mass measured by ultrasound
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Maimónides Biomedical Research Institute of Córdoba
Lead sponsor
Hospital Universitario Reina Sofia de Cordoba
Collaborator
This trial is not recruiting at the moment. You can still explore other options: